Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion

57Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

Epithelial–mesenchymal transition (EMT) is a fundamental process that occurs during embryogenesis and tissue repair. However, EMT can be hijacked by malignant cells, where it may promote immune evasion and metastasis. Classically considered a dichotomous transition, EMT in cancer has recently been considered a plastic process whereby malignant cells display and interconvert among hybrid epithelial/mesenchymal (E/M) states. Epithelial–mesenchymal plasticity (EMP) and associated hybrid E/M states are divergent from classical EMT, with unique immunomodulatory effects. Here, we review recent insights into the EMP-immune crosstalk, highlighting possible mechanisms of immune evasion conferred by hybrid E/M states and roles of immune cells in EMP.

Cite

CITATION STYLE

APA

Mullins, R. D. Z., Pal, A., Barrett, T. F., Heft Neal, M. E., & Puram, S. V. (2022, July 1). Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion. Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/0008-5472.CAN-21-4370

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free